Clinical Trials List
2025-02-11 - 2038-02-19
Phase III
Recruiting8
ICD-10C50.011
Malignant neoplasm of nipple and areola, right female breast
ICD-10C50.012
Malignant neoplasm of nipple and areola, left female breast
ICD-10C50.019
Malignant neoplasm of nipple and areola, unspecified female breast
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9174.0
Malignant neoplasm of female breast, nipple and areola
-
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/13
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 沈士哲 無
- Yung-Chang Lin 無
- Chan-Keng Yang 無
- 周旭恆 無
- Chi-Chang Yu 無
- 阮昱翔 無
- Mengting Peng 無
- Wen-Chi Shen 無
- Wen-Ling Kuo 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 王國鐘
- 劉佳樺 無
- HSIN-CHEN LIN 無
- 楊陽生 無
- ZHENG-WEI ZHOU 無
- 楊捷儒 無
- Kuan-Der Lee
- Huey-En Tzeng 無
- I-Chen Tsai 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 邱仁輝
- Chi-Cheng Huang
- 鄭涵方 無
- 林燕淑
- Yi-Fang Tsai 無
- 陳柏方
- Chun-Yu Liu 無
- Jiun-I Lai 無
- 陳彥蓁
- Ta-Chung Chao
- 賴亦貞 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
60 participants
-
Global
1020 participants
